Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print 50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks

50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks

June 12, 2008

At least 50% of recent onset rheumatoid arthritis patients achieve remission (a state free of signs and symptoms) within 36 weeks when following a systematic approach of step-up DMARD treatment in combination with tight control, according to results of a study presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. Results of this study indicate that achieving remission is not only possible during clinical trials but can be a realistic goal of standard clinical care.

Of 169 early RA patients, remission (defined as DAS28<2.6) was achieved in 15.5% at week 8 (23/148), 22.2% at week 12 (24/108), 30.7% at week 20 (23/75), 38.8% at week 24 (33/85), 52.1% at week 36 (38/73) and 51% at week 48-52 (26/51).




The researchers achieved these results through implementation of a tightly regulated DMARD treatment scheme, as follows:

* Methotrexate 15mg/week was initiated following diagnosis

* If remission was not achieved at week 8, the dose was increased to 25mg/week

* If not achieved at week 12, sulfasalazine was added (2grams/day)

* If not achieved at week 20, the dose was increased to 3grams/day

* If not achieved at week 24 adalimumab was added to methotrexate

* Every 3 months thereafter, therapy could be adjusted based on DAS28, also using other TNF-blockers. Patients were allowed to take NSAIDs, and prednisolone &#8804;10mg/day and intra-articular corticosteroid injections could be administered

Dr. H. Kuper and Prof M. van de Laar of Medisch Spectrum Twente & University Twente, the Netherlands, who led the study, said; "In many large clinical trials, remission can be considered a realistic goal. We set out to determine whether all patients presenting in daily clinical practice can reasonably expect to achieve a state free of signs and symptoms, if a strict treatment schedule was followed. Our results show that remission is indeed achievable in as many as half of clinical practice patients following this schedule, which could indicate that remission is a realistic treatment goal of daily clinical practice."

As part of the Dutch Rheumatoid Arthritis Monitoring Registry (DREAM), investigators performed a prospective descriptive study of a cohort of recent onset rheumatoid arthritis DMARD-naïve, patients in daily clinical practice, between January 2006 and January 2008. 190 consecutive patients with recently diagnosed RA under the care of the rheumatology clinics of three hospitals in the Netherlands were included. Results were taken from the first 169 patients with DAS28>3.2 at inclusion.

At baseline, patient characteristics between the hospitals were comparable - average patient age was 57.3 years (13.7), 63.9% were female, 52.7% of which were rheumatoid factor positive, with an average disease duration of 16 weeks (1-52), ESR 33.2 (20.5), CRP 23.5 (26.4), DAS28 5.1 (1.1), HAQ 1.3 (0.6).

European League Against Rheumatism



Related Rheumatoid Arthritis News Articles Rheumatoid Arthritis News and Current Rheumatoid Arthritis Events RSS Rheumatoid Arthritis News and Current Rheumatoid Arthritis Events RSS
Loss of sleep, even for a single night, increases inflammation in the body
Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs.

Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.

Researchers discover how rheumatoid arthritis causes bone loss
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry.

Protein complementarity may offer new insights into autoimmune diseases
The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December Journal of the American Society of Nephrology (JASN).

New Guidelines for Treating Rheumatoid Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).

Once suspect protein found to promote DNA repair, prevent cancer
An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academies of Science.

Pediatric researchers find possible 'master switch' gene in juvenile arthritis
Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a "master switch" that helps turn on the debilitating disease.

Small protein may have big role in making more bone and less fat
A small protein may have a big role in helping you make more bone and less fat, researchers say.

Complexity of Crohn's disease revealed as 'gene' count tops 30
New research has trebled the number of genetic regions known to be implicated in Crohn's disease, a form of inflammatory bowel disease, to over thirty.

Heavy birthweight babies twice as likely to develop rheumatoid arthritis
Heavy birthweight female babies are twice as likely to develop rheumatoid arthritis in adulthood as their average birthweight peers, suggests research published ahead of print in the Annals of the Rheumatic Diseases.
More Rheumatoid Arthritis News Articles


The New Arthritis Breakthrough: The Only Medical Therapy Clinically Proven to Produce Long-term Improvement and Remission of RA, Lupus, Juvenile RS, Fibromyalgia, ... & Other Inflammatory Forms of Arthritis
by Henry Scammell

...can be miraculous for rheumatoid arthritis sufferers.-- Health & Healing, Tomorrow's Medicine...



Conquering Arthritis: What Doctors Don't Tell You Because They Don't Know: 9 Secrets I Learned the Hard Way
by Barbara D. Allan

This book provides hard-earned, practical, detailed information that is critical for successful healing of arthritis, but that has never before been collected in one book. Without this information many people with arthritis will not get well. The information is organized into a well-researched, easy-to-follow plan for getting well again and includes case histories of people with dramatic and...



The First Year: Rheumatoid Arthritis: An Essential Guide for the Newly Diagnosed (First Year, The)
by M.E.A. McNeil

Rheumatoid arthritis (RA), a disease characterized by inflammation of the joints, is one of the most disabling forms of arthritis and affects over two million people in the United States. Without proper treatment it can lead to long-term joint damage, chronic pain, loss of function, and disability. From the first moment of her diagnosis, author M.E.A. McNeil took charge and educated herself on...



What Your Doctor May Not Tell You About Autoimmune Disorders: The Revolutionary, Drug-Free Treatments for Thyroid Disease, Lupus, MS, IBD, Chronic Fatigue; Rheumatoid Arthritis, and Other Diseases
by Stephen B. Edelson, Deborah Mitchell

Autoimmune disorders are not well understood and therefore difficult to treat. The result is that there are millions of Americans who are suffering because they aren't being diagnosed properly, or getting the correct medical treatment they need. Here, Dr. Edelson discusses the most common types of autoimmune diseases, including lupus, Chron's disease, thyroid disease, rheumatoid arthritis, and...



How to Deal With Back Pain and Rheumatoid Joint Pain
by Fereydoon Batmanghelidj

Dr. Batmanghelidj received his formal medical education at St. Mary's Hospital Medical School of London University. He provides for the layman a clear and comprehensive book on the origins of chronic pain. His clinical and scientific research exposes, for the first time, that recurring "chronic pains" are a signal system of the body indicating severe general or local dehydration. Most of...



The Arthritis Foundation's Guide to Good Living with Rheumatoid Arthritis, 3rd Edition (Arthritis Foundation's Guide to Good Living with Rheumatoid Arthriti)
by Dorothy Foltz-Gray

From the Arthritis Foundation, a trusted source of health information and guidance for more than 50 years, Good Living With Rheumatoid Arthritis, 3rd Edition, explains new research and treatments in clear, simple language. Readers will learn how to be proactive patients, how to stretch daily to reduce pain and increase flexibility, and how to judge the many over-the-counter drugs and supplements...



Arthritis: Fight it with the Blood Type Diet: The Individualized Plan for Defeating the Pain of Osteoarthritis, Rheumatoid (Dr. Peter D'adamo's Eat Right for Your Type Health Library)
by Peter J. D'Adamo, Catherine Whitney

Four blood types, four battle plans to fight arthritis. Bestselling author Dr. Peter J. D'Adamo delivers four unique, individualized battle plans for defeating the pain of osteoarthritis, rheumatoid arthritis, fibromyalgia, and other inflammatory conditions. A new approach to one of the most painful and debilitating health...



What To Do When The Doctor Says It's Rheumatoid Arthritis: Stop Your Pain, Become More Active, and Learn How to Talk to Your Doctors
by Winnie Yu, Harry D. Fischer

Rheumatoid arthritis is a painful, incurable connective-tissue disease that attacks the hands, feet, and joints and may lead to deformities and permanent disabilities. This book, written by a doctor and health journalist will offer comprehensive medical advice and lifestyle information for the nearly three million Americans who suffer from this disease. The book uses mind-body techniques and...



Arthritis Without Pain: The Miracle of TNF Blockers
by Scott J Zashin MD, Laurette Hesser

The Long-Awaited Breakthrough for Arthritis Pain The miracle of TNF blockers is this: they work. Nearly two of every three patients who try these medications get lasting relief from joint pain and inflammation. Known as biologic DMARDs, these high-tech drugs inhibit the action of tumor necrosis factor (TNF), a protein that contributes to joint damage associated with rheumatoid arthritis,...



Living with Rheumatoid Arthritis (Johns Hopkins Press Health Book)
by Tammi L. Shlotzhauer, James L. McGuire

A trusted guide and an invaluable resource, Living with Rheumatoid Arthritis offers practical advice for the millions of people coping with this painful disease. Now thoroughly revised and expanded, in a second edition, this book brings readers up to date with the latest methods of diagnosis and treatment.Building on their accessible explanation of the disease and its causes, the authors describe...

© 2008 BrightSurf.com